Licensed Drug Shortage: Bupropion 150mg Modified Release Tablets

On the 1st December 2022, the DHSC raised an alert of a supply disruption of Bupropion (Zyban) 150mg modified release tablets.

Stock shortages have commenced, with Healthcare Professionals being encouraged to find alternative methods for their patients’ such as Specials (Unlicensed Medicines).

As an MHRA Approved and NHS Accredited Specials Manufacturer, Rokshaw Laboratories can assist with this shortage for Pharmacies and Hospitals across the UK for next day delivery, from our state-of-the-art manufacturing facility based in Sunderland.

 Contact us today to see how we can help you using the following methods: 

• Freephone: 0800 1699 765

• Email: